Morales-Cano, D.; Barreira, B.; De Olaiz Navarro, B.; Callejo, M.; Mondejar-Parreño, G.; Esquivel-Ruiz, S.; Lorente, J.A.; Moreno, L.; Barberá, J.A.; Cogolludo, Á.;
et al. Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension. Antioxidants 2021, 10, 155.
https://doi.org/10.3390/antiox10020155
AMA Style
Morales-Cano D, Barreira B, De Olaiz Navarro B, Callejo M, Mondejar-Parreño G, Esquivel-Ruiz S, Lorente JA, Moreno L, Barberá JA, Cogolludo Á,
et al. Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension. Antioxidants. 2021; 10(2):155.
https://doi.org/10.3390/antiox10020155
Chicago/Turabian Style
Morales-Cano, Daniel, Bianca Barreira, Beatriz De Olaiz Navarro, María Callejo, Gema Mondejar-Parreño, Sergio Esquivel-Ruiz, Jose A. Lorente, Laura Moreno, Joan A. Barberá, Ángel Cogolludo,
and et al. 2021. "Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension" Antioxidants 10, no. 2: 155.
https://doi.org/10.3390/antiox10020155
APA Style
Morales-Cano, D., Barreira, B., De Olaiz Navarro, B., Callejo, M., Mondejar-Parreño, G., Esquivel-Ruiz, S., Lorente, J. A., Moreno, L., Barberá, J. A., Cogolludo, Á., & Perez-Vizcaino, F.
(2021). Oxygen-Sensitivity and Pulmonary Selectivity of Vasodilators as Potential Drugs for Pulmonary Hypertension. Antioxidants, 10(2), 155.
https://doi.org/10.3390/antiox10020155